SUNESIS PHARMACEUTICALS INC: SNSS (Nasdaq Capital Market)
Enter your Email for a Free Trial: 
Free Trial
Form (Filer)  Received ( Period
10-Q SUNESIS PHARMACEUTICALS INC  05/09/13 (03/31/13) 
8-K SUNESIS PHARMACEUTICALS INC  05/09/13 (05/09/13) 
EFFECT SUNESIS PHARMACEUTICALS INC  05/01/13 
DEFA14A SUNESIS PHARMACEUTICALS INC  04/25/13 
DEF 14A SUNESIS PHARMACEUTICALS INC  04/25/13 (06/06/13) 
S-3 SUNESIS PHARMACEUTICALS INC  04/10/13 
8-K SUNESIS PHARMACEUTICALS INC  04/10/13 (04/10/13) 
424B5 SUNESIS PHARMACEUTICALS INC  04/10/13 
8-K SUNESIS PHARMACEUTICALS INC  03/27/13 (03/21/13) 
S-8 SUNESIS PHARMACEUTICALS INC  03/13/13 
10-K SUNESIS PHARMACEUTICALS INC  03/13/13 (12/31/12) 
8-K SUNESIS PHARMACEUTICALS INC  03/13/13 (03/13/13) 
SC 13G SUNESIS PHARMACEUTICALS INC(FMR LLC  03/11/13 
4 SUNESIS PHARMACEUTICALS INC(CRAIG ADAM R  03/01/13 (02/28/13) 
4 SUNESIS PHARMACEUTICALS INC(BJERKHOLT ERIC  03/01/13 (02/28/13) 
4 SUNESIS PHARMACEUTICALS INC(SWISHER DANIEL N JR  03/01/13 (02/28/13) 
8-K SUNESIS PHARMACEUTICALS INC  02/26/13 (02/20/13) 
SC 13G/A SUNESIS PHARMACEUTICALS INC(VISIUM ASSET MANAGEMENT, LP  02/14/13 
SC 13G/A SUNESIS PHARMACEUTICALS INC(RA CAPITAL MANAGEMENT, LLC  02/14/13 
SC 13G/A SUNESIS PHARMACEUTICALS INC(MERLIN BIOMED PRIVATE EQUITY ADVISORS, L.L.C.  02/14/13 
 
 Results 1 - 20 of 460
     [1] 2 3 4 5 6 7 8 9 10   Next 10 Pages [ Show Next 20 Results ] 
Last Trade
Last Trade: 
$5.56  
Change: 
0.04 (0.73%)  
Trade Time: 
May 24  
Market Cap: 
$286.95M
Company People
View Officers and Directors and Other Key Individuals Mentioned in SUNESIS PHARMACEUTICALS INC SEC Filings

Premium Content from Alacrastore.com